| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.0074 | 0.9 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | -0.0069 | 0.9 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | 0.0071 | 0.9 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | 0.0057 | 0.9 |